Clinical Application of
99mTc-pyrophosphate imaging
MRI
echocardiography
light-chain cardiac amyloidosis
transthyretin cardiac amyloidosis
Journal
Journal of nuclear medicine technology
ISSN: 1535-5675
Titre abrégé: J Nucl Med Technol
Pays: United States
ID NLM: 0430303
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
16
02
2023
revised:
10
04
2023
medline:
5
6
2023
pubmed:
3
6
2023
entrez:
2
6
2023
Statut:
ppublish
Résumé
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy resulting from deposition of insoluble amyloid protein in the myocardial interstitium. The accumulation of amyloid protein causes the myocardium to thicken and stiffen, leading to diastolic dysfunction and, eventually, heart failure. Two primary types of amyloidosis-transthyretin and immunoglobulin light chain-account for nearly 95% of all CA diagnoses. Three case studies are presented. The first demonstrates a patient positive for transthyretin amyloidosis, the second demonstrates a patient positive for light-chain CA, and the third demonstrates a patient showing blood-pool uptake on the [
Identifiants
pubmed: 37268320
pii: 51/2/125
doi: 10.2967/jnmt.123.265614
doi:
Substances chimiques
diphosphoric acid
4E862E7GRQ
Diphosphates
0
Amyloidogenic Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-128Informations de copyright
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.